Persistent parvovirus-associated chronic fatigue treated with high dose intravenous immunoglobulin

Pediatr Infect Dis J. 2005 Mar;24(3):272-4. doi: 10.1097/01.inf.0000155194.66797.20.

Abstract

We report a 16-year-old boy with no evidence of immunodeficiency who had a 2-year history of chronic fatigue, low grade fever and slapped-cheek rash associated with chronic parvovirus B19 viremia. Prolonged intravenous immunoglobulin therapy resulted in resolution of his symptoms and viremia. Intravenous immunoglobulin may be useful in the resolution of parvovirus viremia regardless of immune status.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Fatigue Syndrome, Chronic / complications
  • Fatigue Syndrome, Chronic / diagnosis*
  • Follow-Up Studies
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Male
  • Parvoviridae Infections / complications
  • Parvoviridae Infections / diagnosis*
  • Parvoviridae Infections / drug therapy*
  • Parvovirus / isolation & purification*
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous